List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Embolization Particle Product Introduction
1.2 Market by Type
1.2.1 Global Embolization Particle Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Microspheres
1.2.3 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.4 Drug-eluting Beads (DEBs)
1.2.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Market by Application
1.3.1 Global Embolization Particle Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Embolization Particle Sales Estimates and Forecasts 2017-2028
2.2 Global Embolization Particle Revenue Estimates and Forecasts 2017-2028
2.3 Global Embolization Particle Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Embolization Particle Sales by Region
2.4.1 Global Embolization Particle Sales by Region (2017-2022)
2.4.2 Global Sales Embolization Particle by Region (2023-2028)
2.5 Global Embolization Particle Revenue by Region
2.5.1 Global Embolization Particle Revenue by Region (2017-2022)
2.5.2 Global Embolization Particle Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Embolization Particle Sales by Manufacturers
3.1.1 Global Top Embolization Particle Manufacturers by Sales (2017-2022)
3.1.2 Global Embolization Particle Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Embolization Particle in 2021
3.2 Global Embolization Particle Revenue by Manufacturers
3.2.1 Global Embolization Particle Revenue by Manufacturers (2017-2022)
3.2.2 Global Embolization Particle Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Embolization Particle Revenue in 2021
3.3 Global Embolization Particle Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Embolization Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Embolization Particle Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Embolization Particle Sales by Type
4.1.1 Global Embolization Particle Historical Sales by Type (2017-2022)
4.1.2 Global Embolization Particle Forecasted Sales by Type (2023-2028)
4.1.3 Global Embolization Particle Sales Market Share by Type (2017-2028)
4.2 Global Embolization Particle Revenue by Type
4.2.1 Global Embolization Particle Historical Revenue by Type (2017-2022)
4.2.2 Global Embolization Particle Forecasted Revenue by Type (2023-2028)
4.2.3 Global Embolization Particle Revenue Market Share by Type (2017-2028)
4.3 Global Embolization Particle Price by Type
4.3.1 Global Embolization Particle Price by Type (2017-2022)
4.3.2 Global Embolization Particle Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Embolization Particle Sales by Application
5.1.1 Global Embolization Particle Historical Sales by Application (2017-2022)
5.1.2 Global Embolization Particle Forecasted Sales by Application (2023-2028)
5.1.3 Global Embolization Particle Sales Market Share by Application (2017-2028)
5.2 Global Embolization Particle Revenue by Application
5.2.1 Global Embolization Particle Historical Revenue by Application (2017-2022)
5.2.2 Global Embolization Particle Forecasted Revenue by Application (2023-2028)
5.2.3 Global Embolization Particle Revenue Market Share by Application (2017-2028)
5.3 Global Embolization Particle Price by Application
5.3.1 Global Embolization Particle Price by Application (2017-2022)
5.3.2 Global Embolization Particle Price Forecast by Application (2023-2028)
6 North America
6.1 North America Embolization Particle Market Size by Type
6.1.1 North America Embolization Particle Sales by Type (2017-2028)
6.1.2 North America Embolization Particle Revenue by Type (2017-2028)
6.2 North America Embolization Particle Market Size by Application
6.2.1 North America Embolization Particle Sales by Application (2017-2028)
6.2.2 North America Embolization Particle Revenue by Application (2017-2028)
6.3 North America Embolization Particle Market Size by Country
6.3.1 North America Embolization Particle Sales by Country (2017-2028)
6.3.2 North America Embolization Particle Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Embolization Particle Market Size by Type
7.1.1 Europe Embolization Particle Sales by Type (2017-2028)
7.1.2 Europe Embolization Particle Revenue by Type (2017-2028)
7.2 Europe Embolization Particle Market Size by Application
7.2.1 Europe Embolization Particle Sales by Application (2017-2028)
7.2.2 Europe Embolization Particle Revenue by Application (2017-2028)
7.3 Europe Embolization Particle Market Size by Country
7.3.1 Europe Embolization Particle Sales by Country (2017-2028)
7.3.2 Europe Embolization Particle Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Embolization Particle Market Size by Type
8.1.1 Asia Pacific Embolization Particle Sales by Type (2017-2028)
8.1.2 Asia Pacific Embolization Particle Revenue by Type (2017-2028)
8.2 Asia Pacific Embolization Particle Market Size by Application
8.2.1 Asia Pacific Embolization Particle Sales by Application (2017-2028)
8.2.2 Asia Pacific Embolization Particle Revenue by Application (2017-2028)
8.3 Asia Pacific Embolization Particle Market Size by Region
8.3.1 Asia Pacific Embolization Particle Sales by Region (2017-2028)
8.3.2 Asia Pacific Embolization Particle Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Embolization Particle Market Size by Type
9.1.1 Latin America Embolization Particle Sales by Type (2017-2028)
9.1.2 Latin America Embolization Particle Revenue by Type (2017-2028)
9.2 Latin America Embolization Particle Market Size by Application
9.2.1 Latin America Embolization Particle Sales by Application (2017-2028)
9.2.2 Latin America Embolization Particle Revenue by Application (2017-2028)
9.3 Latin America Embolization Particle Market Size by Country
9.3.1 Latin America Embolization Particle Sales by Country (2017-2028)
9.3.2 Latin America Embolization Particle Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Embolization Particle Market Size by Type
10.1.1 Middle East and Africa Embolization Particle Sales by Type (2017-2028)
10.1.2 Middle East and Africa Embolization Particle Revenue by Type (2017-2028)
10.2 Middle East and Africa Embolization Particle Market Size by Application
10.2.1 Middle East and Africa Embolization Particle Sales by Application (2017-2028)
10.2.2 Middle East and Africa Embolization Particle Revenue by Application (2017-2028)
10.3 Middle East and Africa Embolization Particle Market Size by Country
10.3.1 Middle East and Africa Embolization Particle Sales by Country (2017-2028)
10.3.2 Middle East and Africa Embolization Particle Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sirtex Medical
11.1.1 Sirtex Medical Corporation Information
11.1.2 Sirtex Medical Overview
11.1.3 Sirtex Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sirtex Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sirtex Medical Recent Developments
11.2 Merit Medical
11.2.1 Merit Medical Corporation Information
11.2.2 Merit Medical Overview
11.2.3 Merit Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merit Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merit Medical Recent Developments
11.3 Cook Medical
11.3.1 Cook Medical Corporation Information
11.3.2 Cook Medical Overview
11.3.3 Cook Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Cook Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cook Medical Recent Developments
11.4 BTG Medical
11.4.1 BTG Medical Corporation Information
11.4.2 BTG Medical Overview
11.4.3 BTG Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 BTG Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BTG Medical Recent Developments
11.5 Boston Scientific Corporation
11.5.1 Boston Scientific Corporation Corporation Information
11.5.2 Boston Scientific Corporation Overview
11.5.3 Boston Scientific Corporation Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Boston Scientific Corporation Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Boston Scientific Corporation Recent Developments
11.6 Terumo Corporation
11.6.1 Terumo Corporation Corporation Information
11.6.2 Terumo Corporation Overview
11.6.3 Terumo Corporation Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Terumo Corporation Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Terumo Corporation Recent Developments
11.7 HENGRUI Medical
11.7.1 HENGRUI Medical Corporation Information
11.7.2 HENGRUI Medical Overview
11.7.3 HENGRUI Medical Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 HENGRUI Medical Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 HENGRUI Medical Recent Developments
11.8 INterface BIOmaterials B.V.
11.8.1 INterface BIOmaterials B.V. Corporation Information
11.8.2 INterface BIOmaterials B.V. Overview
11.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 INterface BIOmaterials B.V. Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 INterface BIOmaterials B.V. Recent Developments
11.9 Alicon
11.9.1 Alicon Corporation Information
11.9.2 Alicon Overview
11.9.3 Alicon Embolization Particle Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Alicon Embolization Particle Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Alicon Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Embolization Particle Industry Chain Analysis
12.2 Embolization Particle Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Embolization Particle Production Mode & Process
12.4 Embolization Particle Sales and Marketing
12.4.1 Embolization Particle Sales Channels
12.4.2 Embolization Particle Distributors
12.5 Embolization Particle Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Embolization Particle Industry Trends
13.2 Embolization Particle Market Drivers
13.3 Embolization Particle Market Challenges
13.4 Embolization Particle Market Restraints
14 Key Findings in The Global Embolization Particle Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
